first dose of retatrutide 10 mg: vial guide for dosing, reconstitution, and protocols Retatrutide: UK Availability, Price, Side

rolled out top-line phase III data from Triumph-1 showing that all doses of retatrutide met primary and key secondary endpoints for obesity, with participants losing on average between 19% and 28.3% of body weight and significantly improving their cardiovascular risk factors

CrossRef The association of multiple metabolic disorders with the severity of fasting blood glucose and hepatic steatosis in a Chinese population with MAFLD: a cross-sectional study of over 3000 participants Xue Qu, Shanshan Jin, Yuqing Shi, Weisong Zhang, Delong Cong, Yangyang Liu Scientific Reports .2025;[Epub] CrossRef Changes in liver enzymes and cardiometabolic markers in individuals with obesity and metabolic-dysfunction-associated steatohepatitis treated with semaglutide Husam Albarmawi, Firas Dabbous, Abdalla Aly, Alia Yousif, Samuel Huse, Maximilian Jara, Andres Quintero, Eric Lawitz Current Medical Research and Opinion .2025

Quitting it can lead to regaining most of the lost weight

If you hold a Health Savings Account, you may be wondering whether those pre-tax dollars can help

GLP-1 is a hormone the body makes naturally, but it only works for a short time

In clinical trials, doses are escalated gradually over several weeks to improve tolerability a process known as dose titration